117 related articles for article (PubMed ID: 35675348)
1. Propensity score-integrated approach to survival analysis: leveraging external evidence in single-arm studies.
Chen WC; Lu N; Wang C; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 May; 32(3):400-413. PubMed ID: 35675348
[TBL] [Abstract][Full Text] [Related]
2. Propensity score-incorporated adaptive design approaches when incorporating real-world data.
Lu N; Chen WC; Li H; Song C; Tiwari R; Wang C; Xu Y; Yue LQ
Pharm Stat; 2024; 23(2):204-218. PubMed ID: 38014753
[TBL] [Abstract][Full Text] [Related]
3. Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources.
Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 Jan; 32(1):158-169. PubMed ID: 34756158
[TBL] [Abstract][Full Text] [Related]
4. A propensity score-integrated approach for leveraging external data in a randomized controlled trial with time-to-event endpoints.
Chen WC; Lu N; Wang C; Li H; Song C; Tiwari R; Xu Y; Yue LQ
Pharm Stat; 2024 Mar; ():. PubMed ID: 38442919
[TBL] [Abstract][Full Text] [Related]
5. Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data.
Chen WC; Wang C; Li H; Lu N; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2020 May; 30(3):508-520. PubMed ID: 32370640
[TBL] [Abstract][Full Text] [Related]
6. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
Liu M; Bunn V; Hupf B; Lin J; Lin J
Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
[TBL] [Abstract][Full Text] [Related]
7. Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies.
Wang C; Lu N; Chen WC; Li H; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2020 May; 30(3):495-507. PubMed ID: 31707908
[TBL] [Abstract][Full Text] [Related]
8. Leverage multiple real-world data sources in single-arm medical device clinical studies.
Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 Jan; 32(1):107-123. PubMed ID: 33844621
[TBL] [Abstract][Full Text] [Related]
9. Bayesian Divide-and-Conquer Propensity Score Based Approaches for Leveraging Real World Data in Single Arm Clinical Trials.
Baron E; Zhu J; Tang RS; Chen MH
J Biopharm Stat; 2022 Jan; 32(1):75-89. PubMed ID: 35094643
[TBL] [Abstract][Full Text] [Related]
10. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies.
Wang C; Li H; Chen WC; Lu N; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2019; 29(5):731-748. PubMed ID: 31530111
[TBL] [Abstract][Full Text] [Related]
11. Leveraging external evidence using Bayesian hierarchical model and propensity score in the presence of covariates.
Chen X; Yao Y; Wang L; Mukhopadhyay S
Contemp Clin Trials; 2023 Sep; 132():107301. PubMed ID: 37467950
[TBL] [Abstract][Full Text] [Related]
12. Propensity score-based methods for causal inference and external data leveraging in regulatory settings: From basic ideas to implementation.
Li H; Yue LQ
Pharm Stat; 2023; 22(4):721-738. PubMed ID: 36794571
[TBL] [Abstract][Full Text] [Related]
13. Practical considerations of utilizing propensity score methods in clinical development using real-world and historical data.
Li Q; Lin J; Chi A; Davies S
Contemp Clin Trials; 2020 Oct; 97():106123. PubMed ID: 32853779
[TBL] [Abstract][Full Text] [Related]
14. Variance estimators for weighted and stratified linear dose-response function estimators using generalized propensity score.
Garès V; Chauvet G; Hajage D
Biom J; 2022 Jan; 64(1):33-56. PubMed ID: 34327720
[TBL] [Abstract][Full Text] [Related]
15. Principled leveraging of external data in the evaluation of diagnostic devices via the propensity score-integrated composite likelihood approach.
Song C; Li H; Chen WC; Lu N; Tiwari R; Wang C; Xu Y; Yue LQ
Pharm Stat; 2023; 22(3):547-569. PubMed ID: 36871949
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of diagnostic tests for low prevalence diseases: a statistical approach for leveraging real-world data to accelerate the study.
Chen WC; Li H; Wang C; Lu N; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2021 May; 31(3):375-390. PubMed ID: 33615997
[TBL] [Abstract][Full Text] [Related]
17. Subclassification estimation of the weighted average treatment effect.
Choi BY
Biom J; 2021 Dec; 63(8):1706-1728. PubMed ID: 34270815
[TBL] [Abstract][Full Text] [Related]
18. Estimating causal effects in observational studies for survival data with a cure fraction using propensity score adjustment.
Wang Z; Wang C; Wang X
Biom J; 2023 Dec; 65(8):e2100357. PubMed ID: 37672794
[TBL] [Abstract][Full Text] [Related]
19. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
Wang X; Suttner L; Jemielita T; Li X
J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
[TBL] [Abstract][Full Text] [Related]
20. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
Stampf S; Graf E; Schmoor C; Schumacher M
Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
